Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer Treatment

NARecruitingINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

February 21, 2021

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2024

Conditions
Breast Cancer
Interventions
DEVICE

Hyaluronique Acid Gel

Vaginal gel based on HA with liposomal structure applicated 2 times a week

DEVICE

Laser CO2

The laser energy delivered along the vaginal wall heats the tissue without damaging it.

DEVICE

Hyaluronique Acid Injection

HA injection performed under the mucosae (2-3mm in depth) following one injection point every 5mm on the 3 first cm of the vagina and on the posterior part of the introitus.

Trial Locations (1)

94000

RECRUITING

Henri-Mondor Hospital, Créteil

All Listed Sponsors
collaborator

INTERmedic

UNKNOWN

collaborator

Laboratoires Vivacy

INDUSTRY

collaborator

Laboratoires IPRAD PHARMA

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER